Cancer Care In The U.S. - Publications - Faculty & Research - Harvard Business School

Filter Results: (594)

Filter Results: (594)

Show Results For

← Page 5 of 594 Results →

Sort by

Are you looking for?

→Search All HBS Web

March 31, 2022
Article

Two Approaches to Capping Health Care Prices

By: Michael E. Chernew, Maximilian J. Pany and Leemore S. Dafny

High health care prices for the privately-insured contribute to high premiums, which put downward pressure on wages, and induce employers to reduce benefit generosity and charge employees more for coverage. As the average annual premium for family coverage currently... View Details

Keywords: Price Caps; Health Care and Treatment; Price

Find at Harvard

Register to Read

January 19, 2024
Article

Value-Based Health Care Can Transform the Treatment of Patients with Substance Use Disorder

By: Robert S. Kaplan and Sarah E. Wakeman

U.S. overdose deaths currently exceed 100,000 per year. New facilities, known as bridge clinics, are broadening access to high-quality care by offering outpatient substance use disorder (SUD) treatment with few access barriers. But many of the critical services offered... View Details

Keywords: Health Care and Treatment; Cost; Adoption

04 Jun 2007
Research & Ideas

Is Health Care Making You Better—or Dead?

Regina Herzlinger is not afraid to call them as she sees them. And what she sees looking at the American health care industry is a bunch of killers. Not only are hospitals, insurers, employers, Congress, and... View Details

Keywords: by Sean Silverthorne; Health

September 2017 (Revised July 2023)
Case

Adaptive Platform Trials: The Clinical Trial of the Future?

By: Ariel D. Stern and Sarah Mehta

In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details

Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States

2020
Chapter

Health Care Markets a Decade After the ACA: Bigger, but Probably Not Better

By: Leemore S. Dafny

Love it or hate it, the Affordable Care Act (ACA) embraced and extended the role of private markets in financing and delivering health care in the United States. Ten years after the ACA’s passage, it is unclear whether health care markets are better (along a range of... View Details

Keywords: Health Care and Treatment; Markets; Laws and Statutes; Outcome or Result; Health Industry; United States

Find at Harvard

January 28, 2021
Other Article

Lessons from the U.S.'s Rocky Vaccine Rollout

By: Robert S. Huckman and Bradley R. Staats

The rocky rollout of the COVID-19 vaccines is emblematic of many of the problems with the U.S. health care system. The United States is blessed with highly trained, excellent, and compassionate care providers and terrific research and development that has led to novel... View Details

Keywords: Health Care; COVID-19; Vaccines; Operations Improvement; Health Pandemics; Health Care and Treatment; Service Delivery; Operations; Performance Improvement; Health; Health Industry; United States

Find at Harvard

Register to Read

November 8, 2018
Article

Transitioning Payment Models: Fee-for-Service to Value-Based Care

By: Thomas W. Feeley and Namita Seth Mohta

In a survey of the NEJM Catalyst Insights Council in July 2018, 42% of respondents say they think value-based reimbursement models will be the primary revenue model for U.S. health care. Indeed, this transition is already happening. Respondents report that a quarter of... View Details

Keywords: Payment Methods; Value-based Healthcare Reimbursements; Health Care and Treatment; Value; Transformation

30 May 2007
Research & Ideas

Health Care Under a Research Microscope

warranted, says Hamermesh. "Health care is 17 percent of the U.S. economy, so at some level the HBS interest View Details

Keywords: by Sean Silverthorne; Health; Biotechnology

March 2018
Case

Sandra Brown Goes Digital (A): The Promise and Perils of Social Movements in a Healthcare Company

By: Rosabeth Moss Kanter and Jonathan Cohen

As a middle manager at a biotechnology company, Sandra Brown harnessed digital tools and social media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent,... View Details

Keywords: Digital; Engagement; Stakeholder Engagement; Grassroots Movement; Organization Change And Adaptation; Quality; Health Care; Health Care Industry; Career Path; Leading Change; Management; Innovation and Management; Personal Development and Career; Organizational Change and Adaptation; Biotechnology Industry; Health Industry

November 2018
Case

David Hysong and SHEPHERD Therapeutics

By: Ananth Raman, John Masko and Aldo Sesia

In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his... View Details

Keywords: Cancer; Therapeutics; Drugs; Health Care and Treatment; Business Startups; Product Development; Financing and Loans; Growth and Development Strategy; Problems and Challenges

February 2010 (Revised March 2012)
Case

U.S. Healthcare Reform: International Perspectives

By: Arthur A. Daemmrich and Elia Cameron

The national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the... View Details

Keywords: Macroeconomics; Insurance; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Laws and Statutes; Business and Government Relations; Health Industry; Public Administration Industry; Germany; United Kingdom; United States

October 2013
Case

FasterCures: Removing Barriers to Treatments

By: Richard G. Hamermesh and James Weber

In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details

03 Jul 2012
Research & Ideas

HBS Faculty on Supreme Court Health Care Ruling

experts in the health care field, to provide their views on various facets of one of this country's most important and complex problems. Bill George Professor of Management... View Details

Keywords: Re: Multiple Faculty; Health

January–February 2013
Article

Fairness, Efficiency and Flexibility in Organ Allocation for Kidney Transplantation

By: Dimitris Bertsimas, Vivek F. Farias and Nikolaos Trichakis

We propose a scalable, data-driven method for designing national policies for the allocation of deceased donor kidneys to patients on a waiting list, in a fair and efficient way. We focus on policies that have the same form as the one currently used in the United... View Details

Keywords: Health Care Policy; Healthcare; Fairness; Resource Allocation; Policy; Health Care and Treatment; Medical Specialties; Health Industry; United States

Find at Harvard

April 2020
Article

Regulatory Oversight, Causal Inference, and Safe and Effective Health Care Machine Learning

By: Ariel Dora Stern and W. Nicholson Price, II

In recent years, the applications of Machine Learning (ML) in the health care delivery setting have grown to become both abundant and compelling. Regulators have taken notice of these developments and the U.S. Food and Drug Administration (FDA) has been engaging... View Details

Keywords: Machine Learning; Causal Inference; Health Care and Treatment; Safety; Governing Rules, Regulations, and Reforms

Find at Harvard

3 Jun 2005
Other Presentation

How Business Can Lead a Health Care Revolution

By: Michael E. Porter

This presentation draws on a forthcoming book with Elizabeth Olmsted Teisberg (Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press). Earlier publications about the work include the Harvard Business Review article... View Details

Keywords: Health; United States

May–June 2018
Article

Data Uncertainty in Markov Chains: Application to Cost-Effectiveness Analyses of Medical Innovations

By: Joel Goh, Mohsen Bayati, Stefanos A. Zenios, Sundeep Singh and David Moore

Cost-effectiveness studies of medical innovations often suffer from data inadequacy. When Markov chains are used as a modeling framework for such studies, this data inadequacy can manifest itself as imprecision in the elements of the transition matrix. In this paper,... View Details

Keywords: Markov Chains; Cost Effectiveness; Medical Innovations; Colorectal Cancer; Health Care and Treatment; Cost vs Benefits; Innovation and Invention; Mathematical Methods; Health Industry

Find at Harvard

February 2021
Article

Assessment of Electronic Health Record Use Between U.S. and Non-U.S. Health Systems

By: A Jay Holmgren, Lance Downing, David W. Bates, Tait D. Shanafelt, Arnold Milstein, Christopher Sharp, David Cutler, Robert S. Huckman and Kevin A. Schulman

Importance: Understanding how the electronic health record (EHR) system changes clinician work, productivity, and well-being is critical. Little is known regarding global variation in patterns of use.
Objective: To provide insights into which EHR... View Details

Keywords: Electronic Health Records; Health Care and Treatment; Online Technology; Health Industry; Information Technology Industry

Find at Harvard

March 2015 (Revised December 2016)
Case

American Well: The DTC Decision

By: Elie Ofek and Natalie Kindred

In late 2013, telehealth company American Well, which developed a digital platform that allowed patients to conduct online medical consultations with physicians, is considering pursuing a direct-to-consumer (DTC) strategy. Founded in 2006, American Well had, to date,... View Details

21 Nov 2012
Research & Ideas

What Health Care Managers Need to Know--and How to Teach Them

Global health care is entering its most challenging era, with increasing demand for services from consumers newly arrived in the middle class, under-served people, and rapidly... View Details

Keywords: by Paul Guttry; Health; Education

←
5
6
…
29
30
→